Global /South Korea /Healthcare /Drug Manufacturers - General /007460
chevron_leftBack
Aprogen Medicines Inc. logo

Aprogen Medicines Inc.

007460
KRX: 007460 Delayed
3,240KRW -7.6%
2.13 USD
As of 15 June 2026, Aprogen Medicines Inc. has a market cap of $6.17M USD, ranking #45789 globally and #2737 in South Korea. It ranks #4052 in the Healthcare sector, and #1296 in the Drug Manufacturers - General industry.
Global Rank
45789
Country Rank
2737
Sector Rank
4052
Industry Rank
1296
Key Stats
Market Cap
$6.17MUSD
9.36B KRW
Enterprise Value
$347.69MUSD
527.81B KRW
Revenue (TTM)
$77.72MUSD
117.97B KRW
EBITDA (TTM)
-$47.41MUSD
-71.97B KRW
Net Income (TTM)
-$46.25MUSD
-70.2B KRW
EBITDA Margin
-61%
Profit Margin
-60%
PS Ratio
0.8
PB Ratio
0.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Ki-Cheol Lim open_in_new
Employees
256
Founded
2000
Website
aprogen.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-7.6% -93% -94% -97% -97% -97%

News

Loading...

Markets

Exchange Ticker Price
Korea Exchange
MIC: XKRX
PRIMARY
007460
(주)에이프로젠
ISIN: KR7007460009
Shares Out.:
22.211M1 Shares Float: 13.844M2
TV:
SA:
YF:
GF:
BA:
MS:
3,240 KRW
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Aprogen Medicines Inc.

Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs. In addition, it provides Nukon system, a special heat-preservation system that keeps the pipe facility of the internal equipment of the containment building working safely in the pressurized water reactor power plant; foamglas, a cellular glass insulation product; and fireproof insulation works in the POSCO furnaces and boilers. The company was formerly known as Aprogen KIC Inc. and changed its name to Aprogen Medicines Inc. April 2021. Aprogen Medicines Inc. was founded in 2000 and is based in Seongnam-si, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)
Name
Market Cap diff.
PE
$9.16B
13.91T KRW
149K%
-
$6.79B
10.3T KRW
110K%
1958.1
$5.25B
7.97T KRW
85K%
29.9
298380
$4.97B
7.55T KRW
81K%
-
000100
$4.56B
6.92T KRW
74K%
35.9
$4.45B
6.76T KRW
72K%
-
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
12M%
38.1
JNJ
$547.28B
9M%
26.4
ABBV
$360.63B
6M%
97.4
$321.52B
256.25B CHF
5M%
19.9
AZN
$288.84B
215.59B GBP
5M%
27.6
NOVN
$274.65B
218.9B CHF
4M%
20.5
chevron_leftBack